Showing 20 of 9550 recruiting trials
Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab
Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia
👨⚕️ QED Therapeutics SVP, Clinical Development, QED Therapeutics, a BridgeBio company📍 25 sites📅 Started Apr 2026View details ↗
RecruitingNCT05909761 ↗
Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy
Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas
Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
👨⚕️ Ryan Cassaday, MD, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Apr 2026View details ↗
RecruitingNCT07416201 ↗
Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without Thymectomy
👨⚕️ Luigi D Notarangelo, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Apr 2026View details ↗
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
👨⚕️ Alexandra F Freeman, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Apr 2026View details ↗
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis
👨⚕️ William A Gahl, M.D., National Human Genome Research Institute (NHGRI)📍 1 site📅 Started Apr 2026View details ↗
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
👨⚕️ James N Kochenderfer, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Apr 2026View details ↗
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
👨⚕️ Ramya M Ramaswami, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Apr 2026View details ↗
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)
Androgenic Alopecia TH07 Clinical Trial
Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
👨⚕️ Ryan D. Cassaday, MD, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Apr 2026View details ↗
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
👨⚕️ Johannes Oldenburg, Experimental Haematology and Transfusion Medicine, University Clinic Bonn📍 15 sites📅 Started Apr 2026View details ↗
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →